SB Augmentin Composition Patent May Protect U.S. Sales Until 2017
A formulation patent issued for SmithKline Beecham's flagship antibiotic Augmentin may protect the U.S. market for the product until 2017.
A formulation patent issued for SmithKline Beecham's flagship antibiotic Augmentin may protect the U.S. market for the product until 2017.